As of 2026-04-03, the Intrinsic Value of China Botanic Pharmaceutical Inc (CBPI) is -0.04 USD. This CBPI valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.07 USD, the upside of China Botanic Pharmaceutical Inc is -163.97%.
Based on its market price of 0.07 USD and our intrinsic valuation, China Botanic Pharmaceutical Inc (CBPI) is overvalued by 163.97%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.04 - -0.04 | -0.04 | -163.97% |
| P/E | (0.02) - (0.02) | (0.02) | -132.8% |
| DDM - Stable | (0.02) - (0.10) | (0.06) | -184.6% |
| DDM - Multi | (0.02) - (0.07) | (0.03) | -140.4% |
| Market Cap (mil) | 13.56 |
| Beta | 1.00 |
| Outstanding shares (mil) | 199.34 |
| Enterprise Value (mil) | 13.64 |
| Market risk premium | 4.24% |
| Cost of Equity | 8.01% |
| Cost of Debt | 5.00% |
| WACC | 8.00% |